Together, the two companies aim to accelerate and enhance the development of novel therapeutics by improving antigen presentation and immune responses, a critical step in antibody discovery. The ...
This approach could transform radiation therapy by allowing higher doses to be used more safely, ultimately improving outcomes for cancer patients.